- Home
- CSCI vs SANW Comparison
CSCI vs SANW Comparison
Compare CSCI & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSCI
- SANW
- Stock Information
- Founded
- CSCI 1990
- SANW 1980
- Country
- CSCI Canada
- SANW United States
- Employees
- CSCI N/A
- SANW N/A
- Industry
- CSCI
- SANW Farming/Seeds/Milling
- Sector
- CSCI
- SANW Consumer Staples
- Exchange
- CSCI NYSE
- SANW Nasdaq
- Market Cap
- CSCI 10.5M
- SANW 11.6M
- IPO Year
- CSCI 1996
- SANW 2010
- Fundamental
- Price
- CSCI $3.61
- SANW $5.48
- Analyst Decision
- CSCI
- SANW Strong Buy
- Analyst Count
- CSCI 0
- SANW 1
- Target Price
- CSCI N/A
- SANW $25.00
- AVG Volume (30 Days)
- CSCI 3.3K
- SANW 6.3K
- Earning Date
- CSCI 05-13-2025
- SANW 05-15-2025
- Dividend Yield
- CSCI N/A
- SANW N/A
- EPS Growth
- CSCI N/A
- SANW N/A
- EPS
- CSCI N/A
- SANW N/A
- Revenue
- CSCI $9,030,000.00
- SANW $54,993,808.00
- Revenue This Year
- CSCI N/A
- SANW N/A
- Revenue Next Year
- CSCI N/A
- SANW $14.25
- P/E Ratio
- CSCI N/A
- SANW N/A
- Revenue Growth
- CSCI 36.51
- SANW 6.91
- 52 Week Low
- CSCI $1.96
- SANW $2.10
- 52 Week High
- CSCI $7.72
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- CSCI N/A
- SANW 49.38
- Support Level
- CSCI N/A
- SANW $5.36
- Resistance Level
- CSCI N/A
- SANW $5.88
- Average True Range (ATR)
- CSCI 0.00
- SANW 0.35
- MACD
- CSCI 0.00
- SANW 0.04
- Stochastic Oscillator
- CSCI 0.00
- SANW 57.02
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.